Status:
COMPLETED
How Future Surgery Will Benefit From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Related Measures Perspective From Italian Young Surgeon Society (SPIGC)
Lead Sponsor:
University of Rome Tor Vergata
Collaborating Sponsors:
SPIGC
Conditions:
COVID-19
Health Behavior
Eligibility:
All Genders
18+ years
Brief Summary
The coronavirus 2019 pandemic (COVID-19) strongly affected clinical care worldwide. Due to a shortage of hospitals and beds in intensive care units (ICU), in Italy during outbreaks, surgical resources...
Detailed Description
The purpose of this investigation, organized by the Italian Young Surgeon Society (S.P.I.G.C.), is to establish the impact of the coronavirus 2019 pandemic (COVID-19) on clinical care in Italy. There...
Eligibility Criteria
Inclusion
- Resident, Fellow, PhD candidate, consultant or attending surgeon in Italy in the following surgical specialties: cardiothoracic surgery, colon and rectal surgery, general surgery, gynecology and obstetrics, gynecologic oncology, neurological surgery, ophthalmic surgery, oral and maxillofacial surgery, orthopedic surgery, otorhinolaryngology, pediatric surgery, plastic and maxillofacial surgery, urology, and vascular surgery
Exclusion
- undergraduate students
- Non-Surgical consultant
Key Trial Info
Start Date :
March 16 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
581 Patients enrolled
Trial Details
Trial ID
NCT05323851
Start Date
March 16 2022
End Date
July 1 2022
Last Update
November 21 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienza ospedaliera S. Camillo Forlanini
Roma, Rome, Italy, 00152
2
Policlinico Universitario Campus Bio-Medico
Roma, Italy, 00128
3
Università degli Studi di Roma Tor Vergata
Roma, Italy, 00133